These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34666623)

  • 1. Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/ low-density lipoprotein receptor (LDLR).
    Ji J; Feng M; Niu X; Zhang X; Wang Y
    Bioengineered; 2021 Dec; 12(1):8057-8066. PubMed ID: 34666623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.
    Yang SH; Xu RX; Cui CJ; Wang Y; Du Y; Chen ZG; Yao YH; Ma CY; Zhu CG; Guo YL; Wu NQ; Sun J; Chen BX; Li JJ
    Cardiovasc Diabetol; 2018 Apr; 17(1):48. PubMed ID: 29618348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of miR-7 on Hcy-induced rat cerebral arterial vascular smooth muscle cell proliferation, migration and inflammatory factor expression by targeting MMP-14 to regulate TLR4/NF-κB signaling pathway.
    Ma H; Wang L; Lv W; Lv Z
    Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):12-17. PubMed ID: 33287916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway.
    Zhang M; Li F; Wang X; Gong J; Xian Y; Wang G; Zheng Z; Shang C; Wang B; He Y; Wang W; Lin R
    Histochem Cell Biol; 2020 May; 153(5):357-366. PubMed ID: 32124010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Herp alleviates hyperhomocysteinemia mediated atherosclerosis through the inhibition of vascular smooth muscle cell phenotype switching.
    Lin H; Ni T; Zhang J; Meng L; Gao F; Pan S; Luo H; Xu F; Ru G; Chi J; Guo H
    Int J Cardiol; 2018 Oct; 269():242-249. PubMed ID: 30017525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression.
    Wang D; Yang X; Chen Y; Gong K; Yu M; Gao Y; Wu X; Hu H; Liao C; Han J; Duan Y
    J Biol Chem; 2020 Nov; 295(47):15870-15882. PubMed ID: 32913121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.
    Ferri N; Tibolla G; Pirillo A; Cipollone F; Mezzetti A; Pacia S; Corsini A; Catapano AL
    Atherosclerosis; 2012 Feb; 220(2):381-6. PubMed ID: 22176652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of Herpud1 in the homocysteine-induced phenotypic switching of vascular smooth muscle cells].
    Lin H; Zhang J; Meng LP; Ni TJ; Gao FD; Chi JF; Guo HY; Xu FK
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jul; 47(7):561-569. PubMed ID: 31365998
    [No Abstract]   [Full Text] [Related]  

  • 10. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.
    Weider E; Susan-Resiga D; Essalmani R; Hamelin J; Asselin MC; Nimesh S; Ashraf Y; Wycoff KL; Zhang J; Prat A; Seidah NG
    J Biol Chem; 2016 Aug; 291(32):16659-71. PubMed ID: 27284008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exploring the active ingredient of Chinese yellow wine which could inhibit the Hcy induced proliferation and migration of vascular smooth muscle cells].
    Meng LP; Zhou CZ; Guo Y; Zhai XY; Jiang CJ; Li G; Chi JF; Guo HY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Sep; 31(5):437-42. PubMed ID: 26827537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone ⅡA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling.
    Li Y; Chen F; Guo R; Jia S; Li W; Zhang B
    Biochem Biophys Res Commun; 2020 Jan; 522(1):157-163. PubMed ID: 31757424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.
    Yang X; Zhang J; Chen L; Wu Q; Yu C
    Exp Cell Res; 2018 May; 366(2):152-160. PubMed ID: 29548750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
    Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
    Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.
    Xu L; Hao H; Hao Y; Wei G; Li G; Ma P; Xu L; Ding N; Ma S; Chen AF; Jiang Y
    J Cell Mol Med; 2019 Jul; 23(7):4611-4626. PubMed ID: 31104361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine-induced proliferation of vascular smooth muscle cells occurs via PTEN hypermethylation and is mitigated by Resveratrol.
    Ma SC; Zhang HP; Jiao Y; Wang YH; Zhang H; Yang XL; Yang AN; Jiang YD
    Mol Med Rep; 2018 Apr; 17(4):5312-5319. PubMed ID: 29393420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor).
    Ben Djoudi Ouadda A; Gauthier MS; Susan-Resiga D; Girard E; Essalmani R; Black M; Marcinkiewicz J; Forget D; Hamelin J; Evagelidis A; Ly K; Day R; Galarneau L; Corbin F; Coulombe B; Çaku A; Tagliabracci VS; Seidah NG
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1996-2013. PubMed ID: 31553664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of rosuvastatin in homocysteine induced mouse vascular smooth muscle cell dedifferentiation and endoplasmic reticulum stress and its mechanisms].
    Zhou CZ; Pan SL; Lin H; Meng LP; Ji Z; Chi JF; Guo HY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):43-48. PubMed ID: 29926658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease.
    Guo Y; Tang Z; Yan B; Yin H; Tai S; Peng J; Cui Y; Gui Y; Belke D; Zhou S; Zheng XL
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):67-86. PubMed ID: 34809446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.